Key facts
- Orreco’s last known valuation is $64.8M (Jan 2025).
- It has raised $16.9M; the latest was Later Stage VC ($4.0M) in Dec 2025.
- Notable investors include Enterprise Ireland, Realm Capital Ventures, True Ventures, 20VC, LAUNCH Fund — 38 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 38 names
- ·Watchlist + deal alerts for Orreco
- ·The full record, as it builds
Funding rounds
No funding rounds for Orreco are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Orreco
Developer of a sports analytics platform designed to deliver optimized athlete performance. The company's platform provides physiological and biomarker data, assisting coaches to ask performance-related questions and receive evidence-based answers that reveal insights into how players can improve performance, enabling teams and athletes to make decisions about their performance, nutrition, training, sleep, and recovery.
- Sector
- Healthcare
- HQ
- Galway, Ireland
- Founded
- 2010
- Employees
- 48
- Website
- orreco.com/
- Ownership
- Privately Held (backing)
Orreco doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Orreco shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Orreco in its N-PORT filings yet. We sweep new filings monthly.